Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TIZIANA LIFE SCIENCES PLC. We currently have 9 research reports from 3 professional analysts.
Frequency of research reports
Research reports on
TIZIANA LIFE SCIENCES PLC
TIZIANA LIFE SCIENCES PLC
17 Nov 16
"The Fed's Patrick Harker yesterday spelt out just how complex policy on interest rates has now become. Janet Yellen's own testimony this afternoon, which is seen as key to December's FOMC decision, will have to grapple with all the new uncertainties injected by the President-elect, ranging from regressive tax cuts, booming infrastructure spending, financial deregulation and cuts in federal spending. No easy task, even if the markets appear more convinced than ever that the first hike since 2006 will be delivered next month and that this will be the first of a series of such moves over the subsequent 18 or so months as inflation climbs. The recent phase of asset repricing, nevertheless, took a breather yesterday, with all principal markets making only fractional movements. The Dow Jones broke its record run to drift into the red as financials retrenched, while momentum in technology stocks meant the NASDAQ still managed to close modestly up. Asia also put in just marginal movements across the board, as oil prices went lower on weekly data detailing a large rise in inventories, while the Bank of Japan surprised traders with its plans to buy unlimited JGBs at fixed rates in its latest daily market operation. The latter, of course, being seen as it effort to ensure domestic rates do not find themselves shackled to the US T-bill's upward movements. Today, the UK is due to release retail sales figures while the CML provides mortgage lending data; Eurozone inflation numbers are also expected this morning. Clearly the principal event of the day, however, will be Janet Yellen's Testimony on Capitol Hill which is due to commence at 10:00hrs EST and likely overshadow speeches also due from the Fed's William Dudley and Lael Brainard; the US is due to release inflation, weekly jobless claims and export statistics this afternoon as well. Another busy day for UK corporates, with earnings or trading updates scheduled from the likes of CRH (CRH.L), Great Portland Estates (GPOR.L), Johnson Matthey (JMAT.L), Kier Group (KIER.L), Premier Oil (PMO.L), Royal Mail (RMG.L), Shanks (SKS.L), Ted Baker (TED.L), TT Electronics (TTG.L) and Watkin Jones (WJG.L). The FTSE-100 is expected to open virtually unchanged." - Barry Gibb, Research Analyst
N+1 Singer - Small-cap quantitative research - New momentum screen + 10 “trendy friendlies”
28 Jul 16
We present here our new momentum screen, which is intended to track the behaviour of small-cap shares experiencing the most positive technical momentum. This represents the third of our style baskets, with value and consistent growth themes already established. This is not intended to address the perennial tension between technical and fundamental analysts, merely to investigate behaviour over time. Of the 25 stocks in the basket, we have focussed on 10 which we know and believe to be particularly interesting. With the widely used dictum “the trend is your friend” in mind, we have dubbed them the “trendy friendlies”. We will monitor performance and refresh the screen in 3-4 months’ time.
18 Jul 16
"This morning's announcement that Japan's Sofbank Group, the multinational telecommunications and Internet corporation, has concluded a recommended takeover of ARM Holdings, one of the UK's biggest technology companies, at close to a 50% premium to its closing market value on Friday, is a clear reminder that Sterling's post-Brexit devaluation opens new opportunities for acquisitive internationals. ARM shareholders will be asked to vote on the £24.3bn deal shortly, although Softbank's apparent commitment to double the size of the target's workforce over the next five years, in order to cope with an expected demand explosion for 'Internet of Things' related technologies is, at least, one sign for the UK's new Prime Minister that Brexit has not created an insurmountable barrier to foreign investments. Against this background, London equities are called higher on the open, with the FTSE-100 seen up around 25 points. Sterling and Euro both suffered over the weekend, as safe haven buying pushed investors back into US$ as the Turkish Lira collapsed on response to the country's attempted coup. The Dow Jones Industrial Average hit its fourth consecutive record closing on Friday, albeit in relatively quiet trading across all benchmarks. Asia was more active, this time being led by China which reported slowing monthly house prices; with Japan on public holiday, the Shanghai Composite stood out as the day's main fallers while Hong Kong and Australia put in minor gains. The UK is not due to report any significant macro data today and no major corporates are slated to release trading updates or figures. On this basis, talking points are likely to centre on the recommended ARM takeover, as dealers scan other technology stocks that might similarly become vulnerable to international bargain hunters, and also the Secretary of State, David Davis', warning to the recent, post-Brexit flood of EU migrants that a cut-off point may prospectively limit numbers of those allowed to stay prior to Britain concluding its divorce from the Eurozone.
08 Jun 16
"Equities in London appear set to open down this morning, with the FTSE-100 losing around 14 points in early trade. Sterling and UK equities appear to have been somewhat spooked by recent opinion polls suggesting the Brexit „leave‟ campaigners are now winning more of the wavering vote as June 23rd approaches. This, together with caution ahead of today‟s industrial production data, which is not expected to show any cause for optimism, leaves investors in a sombre mood. The overnight mood in the US was somewhat better, with the S&P 500 and the Dow industrials squeezing-out modest gains and taking indexes close to fresh highs driven primarily by a rally in the energy sector. By comparison, this morning‟s Asian trade left the main territories down, with China leading the way on poor trade data showing exports declining 4.1% year-onyear, sharply below market consensus. As well as release of the UK industrial production and manufacturing output data, investors should watch for RICS residential house prices this morning; later this afternoon, the US weekly petroleum status report is also due. Among the corporates,J Sainsbury is due to release a trading statement on the market open." - Barry Gibb, Research Analyst
N+1 Singer - Morning Song 05-12-2016
05 Dec 16
RTHM is acquiring a profitable Canadian listed mobile specialist for equivalent of US$42.5m consideration in shares (88.235m). This helps adds to two growth vectors RTHM is targeting; (i) adds unique exclusive audience (10m unique) and (ii) Exclusive demand Yahoo and Facebook. The business has 15 premium and owned and operated apps which provide users with rewards for activity. The business is expected to deliver c$9m of EBITDA in FY18 including $2m of cost synergies. This equates to just 4.7x EV/EBITDA. This marks what we see the first step in RTHM activity to scale the business and deliver on margin potential (see our initiation notes). Our initial estimates for EPS revisions are very significant - for FY18 are 2.3 cents (currently 0.6) and for FY19 4.3 (currently 2.5). There is a call at 830 for investors and we will revise post this.
Panmure Morning Note 02-12-16
02 Dec 16
We expect CareTech to report FY results to September on 8th December. A positive trading update in October indicated that performance for the year was in line with market expectations therefore we are focusing on the outlook. We expect a confident statement since the end of 2016 showed positive trends across fee rates, expansion in places and occupancy. We believe CareTech is well positioned for further expansion, and remains at an attractive valuation. We retain our BUY and 380p price target.
N+1 Singer - Morning Song 06-12-2016
06 Dec 16
With FY16 volume and revenue already disclosed in the pre-close, the focus in today’s prelims is on PBT (£100.3m versus our £101m) and EPS (96.8p versus our 95.4p). No special dividend triggered this year (none forecast) and DPS is held at 46.8p (N1SE: 48.0p). On end markets, recent commentary is reiterated – the core business is growing, whilst consumer electronics will be subdued in the current year (competitive capacity from Solvay). On currency, there will be a material benefit in the current year (a little more than the £14m to £15m previously indicated), and a further tailwind next year if current rates are maintained (quantum TBC). There is also an investment of £10m today in a minority interest in Magma Global, Victrex’ oil and gas mega programme partner. Although the share price is now close to our TP of 1730p, we feel that there is enough in today’s announcement to retain a positive stance on medium term opportunities with strong cashflow and a special dividend potentially to look forward to in the current year.
Panmure Morning Note 05-12-16
05 Dec 16
This week will see Chi-Med present data on both fruquintinib and epitinib at the 17th World Conference on Lung Cancer, concerning two proof-of-concept trials in non-small cell lung cancer (NSCLC). This morning, the poster presentation ‘A Phase I Study of Epitinib To Evaluate Efficacy And Safety In EGFR Mutation Positive (EGFRm+) NSCLC Patients With Brain Metastasis’ is available for investors to view on Chi-Med’s website.
Panmure Morning Note 01-12-16
01 Dec 16
Last month we highlighted the ongoing trajectory of Tuzistra sales, noting the impact of significant investment in the modified marketing strategy for Tuzistra, supported by the step up in sales personnel and increased marketing expenditure. This morning’s AGM statement and trading update gives some further colour on progress.